Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression

Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1114-22. doi: 10.1152/ajpgi.00528.2006. Epub 2006 Dec 14.

Abstract

Pregnane X receptor (PXR) expression was shown to be protective in inflammatory bowel disease (IBD). However, the mechanism by which PXR provides protection remains unclear. Wild-type and Pxr-null mice were treated with the PXR agonist pregnenolone-16alpha-carbonitrile or vehicle and administered 2.5% dextran sulfate sodium (DSS) in drinking water to induce IBD. Typical clinical symptoms were evaluated on a daily basis. In vivo intestinal permeability assays and proinflammatory cytokine analysis were performed. PXR agonist-treated mice were protected from DSS-induced colitis compared with vehicle-treated mice, as defined by body weight loss, diarrhea, rectal bleeding, colon length, and histology. Pregnenolone-16alpha-carbonitrile did not decrease the severity of IBD in Pxr-null mice. PXR agonist treatment did not increase epithelial barrier function but did decrease mRNA expression of several NF-kappaB target genes in a PXR-dependent manner. The present study clearly demonstrates a protective role for PXR agonist in DSS-induced IBD. The data suggest that PXR-mediated repression of NF-kappaB target genes in the colon is a critical mechanism by which PXR activation decreases the susceptibility of mice to DSS-induced IBD.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / biosynthesis
  • ATP-Binding Cassette Transporters / genetics
  • Animals
  • Colitis / chemically induced
  • Colitis / genetics
  • Colitis / metabolism
  • Colitis / prevention & control*
  • Colon / drug effects
  • Colon / metabolism
  • Colon / pathology
  • Cytokines / genetics
  • Cytokines / metabolism
  • Cytoprotection / drug effects
  • Dextran Sulfate
  • Disease Models, Animal
  • Gastrointestinal Agents / pharmacology*
  • Gastrointestinal Agents / therapeutic use
  • Gene Expression / drug effects
  • Glutathione Transferase / biosynthesis
  • Glutathione Transferase / genetics
  • HCT116 Cells
  • Humans
  • Inflammatory Bowel Diseases / chemically induced
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / metabolism
  • Inflammatory Bowel Diseases / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Pregnane X Receptor
  • Pregnenolone Carbonitrile / pharmacology*
  • Pregnenolone Carbonitrile / therapeutic use
  • RNA, Messenger / metabolism
  • Receptors, Steroid / agonists*
  • Receptors, Steroid / deficiency
  • Receptors, Steroid / genetics
  • Receptors, Steroid / metabolism
  • Repressor Proteins / agonists
  • Repressor Proteins / metabolism
  • Severity of Illness Index
  • Time Factors
  • Transfection

Substances

  • ATP-Binding Cassette Transporters
  • Cytokines
  • Gastrointestinal Agents
  • NF-kappa B
  • Pregnane X Receptor
  • RNA, Messenger
  • Receptors, Steroid
  • Repressor Proteins
  • Pregnenolone Carbonitrile
  • Dextran Sulfate
  • Glutathione Transferase